Australia's Tissue Repair eyes best day in over 7 months on US patent

Tissue Repair

19/12/2023 04:40

** Shares of Tissue Repair  TRP.AX  rise as much as 14.3% to
A$0.240, set for its best day since June 2 - if current gains
hold 
    ** Stock hits highest level since Dec 8 
    ** Clinical-stage biopharmaceutical firm receives third U.S.
patent for Glucoprime 
    ** Glucoprime is part of co's lead drug candidate TR987 for
the treatment of Venous Leg Ulcers (VLUs)
    ** Stock has fallen 8.7% this year, as of last close

 (Reporting by Sneha Kumar in Bengaluru)
 ((Sneha.Kumar@thomsonreuters.com;))